Literature DB >> 18696247

Pharmacokinetics and pharmacodynamics in the newborn.

I Eberini1.   

Abstract

Pharmacokinetics and pharmacodynamics in the newborn are multifaceted: maturation processes of the systems committed to absorption, distribution, metabolism, and excretion partially overlap, making the newborn an extremely dynamic system, especially if compared with adults. In this short note, some of the relevant variables able to regulate these processes are reviewed according to published literature data.

Mesh:

Substances:

Year:  2008        PMID: 18696247     DOI: 10.1007/s11259-008-9087-1

Source DB:  PubMed          Journal:  Vet Res Commun        ISSN: 0165-7380            Impact factor:   2.459


  6 in total

Review 1.  Pharmacokinetics in the newborn.

Authors:  Jane Alcorn; Patrick J McNamara
Journal:  Adv Drug Deliv Rev       Date:  2003-04-29       Impact factor: 15.470

Review 2.  Developing drugs for pediatric use: a role for juvenile animal studies?

Authors:  Paul Baldrick
Journal:  Regul Toxicol Pharmacol       Date:  2004-06       Impact factor: 3.271

3.  Pharmacokinetics of enrofloxacin in newborn and one-week-old calves.

Authors:  L Kaartinen; S Pyörälä; M Moilanen; S Räisänen
Journal:  J Vet Pharmacol Ther       Date:  1997-12       Impact factor: 1.786

4.  Isolation, purification, and structural characterization of flunixin glucuronide in the urine of greyhound dogs.

Authors:  T C Brady; A J Kind; W H Hyde; M Favrow; D W Hill
Journal:  Drug Metab Dispos       Date:  1998-04       Impact factor: 3.922

Review 5.  Differences in absorption, distribution, metabolism and excretion of xenobiotics between the paediatric and adult populations.

Authors:  M Strolin Benedetti; R Whomsley; E L Baltes
Journal:  Expert Opin Drug Metab Toxicol       Date:  2005-10       Impact factor: 4.481

6.  Pharmacokinetics of flunixin in the cat: enterohepatic circulation and active transport mechanism in the liver.

Authors:  Y Horii; M Ikenaga; M Shimoda; E Kokue
Journal:  J Vet Pharmacol Ther       Date:  2004-04       Impact factor: 1.786

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.